December 20, 2025 08:40 pm (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
PM Modi slams ‘cut and commission’ TMC in virtual Taherpur address | US launches Operation Hawkeye Strike in Syria targeting ISIS after Americans killed | Horror on tracks: Rajdhani Express ploughs into elephant herd, eight killed in Assam | Horror in Bangladesh: Hindu man lynched and set on fire amid violent protests | Bangladesh in flames: Student leader Sharif Osman Hadi's death triggers massive protests, media offices torched | Chaos in Dhaka! Protesters assault New Age Editor, burn down newspaper offices amid deadly unrest | After campus shootings, Trump suspends green card lottery programme | ‘Worst is over,’ says IndiGo CEO after flight chaos; staff told to ignore speculation | Chaos at Hyderabad's Lulu Mall! Nidhhi Agerwal swarmed by fans, police register case | TCS bets big on AI, shares spike as company reveals ambitious plan

Cabinet approves five year’s extension of Biomedical Research Career Programme

| @indiablooms | Mar 27, 2019, at 05:30 pm

New Delhi, Mar 27 (IBNS): The Union Cabinet, chaired by the Prime Minister Narendra Modi, has approved the continuation of the Biomedical Research Career Programme (BRCP), and Wellcome Trust (WT) /  DBT India Alliance beyond its initial 10-year term (2008-09 to 2018-29) to a new five year phase (2019-20 to 2023-24) with Department of Biotechnology (DBT) increasing its commitment to two times that of WT.

The total financial implication will be Rs. 1092 crore with DBT and WT contributing Rs.728 crore and Rs.364 crore respectively.

Over its 10 years of funding in a 1:1partnership, the Programme has fulfilled its objectives of building and nurturing talent of highest global standards in cutting-edge biomedical research in India, which has led to important scientific breakthroughs and applications to meet societal needs.

BRCP has made it attractive for high quality Indian scientists working abroad to return to India, and has increased the number of locations geographically within India where world-class biomedical research is undertaken.

In the extending phase, the Programme would continue to build this capacity as also strengthen clinical research and work towards addressing important health challenges for India.  Continuation of the Programme with increased stake from the Government of India is important to bring about these returns.

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.